Loading clinical trials...
Loading clinical trials...
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors
Conditions
Interventions
ES-481
Placebo
Locations
1
Canada
Clinique Neuro-Levis
Lévis, Quebec, Canada
Start Date
November 21, 2021
Primary Completion Date
December 31, 2023
Completion Date
December 31, 2023
Last Updated
March 2, 2023
Lead Sponsor
ES Therapeutics Australia Pty Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions